Zaibo Li, MD, PhD
College of Medicine
Asst Professor - Clinical
Molecular Biology and Cancer Genetics
Uterine Cervical Cancer ● Carcinoma ● Cancer ● Adenocarcinoma ● Breast Cancer ● Papillomavirus Infections ● Papilloma ● Carcinoma, Squamous Cell ● Neoplasm Invasiveness ● Carcinoma in Situ
Zaibo Li, MD, PhD, is a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James, where his research focuses on breast and gynecologic pathology.In particular, he is interested in breast cancer biomarkers, especially HER2 and checkpoint immune markers, as well as endometrial and cervical cancer, and screening programs for cervical cancer. His recent studies demonstrated that HER2 intratumoral heterogeneity detected by a novel, HER2 gene-protein assay plays an important role in predicting response to anti-HER2 targeted therapy. It also found that checkpoint immune markers play important roles in breast cancer patients’ survival and response to chemotherapy. Dr. Li has co-authored numerous articles in well-respected publications, including American Journal of Clinical Pathology, Modern Pathology and Breast Cancer Research and Treatment.